Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 42,000 shares at $21.18 ($884K) on 2022-10-12, disclosed to the SEC on 2022-10-13.
Open-market sale of $884k RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.36 | 14,000 | $299K | 33.8% |
| 2 | $21.18 | 14,000 | $297K | 33.6% |
| 3 | $20.58 | 14,000 | $288K | 32.6% |
| Total | $21.04 avg | 42,000 | $884K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |